María Cruz

Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort

Pedro David Wendel‐Garcia, Thierry Fumeaux, Philippe Guerci et al. · EClinicalMedicine · 2020 · 229 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +9

Real-Time PCR Assay for Detection and Quantification of Leishmania (Viannia) Organisms in Skin and Mucosal Lesions: Exploratory Study of Parasite Load and Clinical Parameters

Marlene Jara, Vanessa Adaui, Braulio M. Valencia et al. · Journal of Clinical Microbiology · 2013 · 117 citations · Full text

Veterinary Medicine, Dermatology, Infectious Diseases +17

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

William O’Riordan, Alison J. McManus, Jüri Teras et al. · Clinical Infectious Diseases · 2018 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series

Miguel M. Cabada, Martha López, María Cruz et al. · PLoS neglected tropical diseases · 2016 · 81 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony

César Miranda‐Verástegui, Gianfranco Tulliano, Theresa W. Gyorkos et al. · PLoS neglected tropical diseases · 2009 · 79 citations · Full text

Pharmacy, Dermatology, Infectious Diseases +13